[
  {
    "date": "2023-09-29",
    "symbol": "CTXR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 26480928,
    "prepaidexpensecurrent": 7889506,
    "assetscurrent": 34370434,
    "propertyplantandequipmentnet": 1432,
    "operatingleaserightofuseasset": 454426,
    "depositsassets": 38062,
    "inprocessresearchanddevelopment": 59400000,
    "goodwill": 9346796,
    "otherassets": 68784858,
    "assets": 103611150,
    "accountspayablecurrent": 2927334,
    "accruedliabilitiescurrent": 476300,
    "employeerelatedliabilitiescurrent": 2156983,
    "operatingleaseliabilitycurrent": 218380,
    "liabilitiescurrent": 5778997,
    "deferredincometaxliabilitiesnet": 6137800,
    "operatingleaseliabilitynoncurrent": 262865,
    "liabilities": 12179662,
    "commonstockvalue": 158858,
    "additionalpaidincapital": 252903629,
    "retainedearningsaccumulateddeficit": -162231379,
    "stockholdersequity": 90831108,
    "minorityinterest": 600380,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 91431488,
    "liabilitiesandstockholdersequity": 103611150,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 158857798,
    "commonstocksharesoutstanding": 158857798,
    "researchanddevelopmentexpense": 14819729,
    "generalandadministrativeexpense": 15295584,
    "sharebasedcompensation": 6616705,
    "operatingexpenses": 36732018,
    "operatingincomeloss": -36732018,
    "investmentincomeinterest": 1179417,
    "othernonoperatingincome": 3585689,
    "nonoperatingincomeexpense": 4765106,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -31966912,
    "incometaxexpensebenefit": 576000,
    "netincomeloss": -32542912,
    "deemeddividendonwarrantextension": 1151208,
    "netincomelossavailabletocommonstockholdersbasic": -33694120,
    "incomelossfromcontinuingoperationsperbasicshare": -0.22,
    "weightedaveragenumberofsharesoutstandingbasic": 151294729,
    "incomelossfromcontinuingoperationsperdilutedshare": -0.22,
    "weightedaveragenumberofdilutedsharesoutstanding": 151294729,
    "sharesoutstanding": 158857798,
    "stockissuedduringperiodvalueissuedforservices": 100,
    "stockissuedduringperiodsharesissuedforservices": 100000,
    "stockissuedduringperiodvaluestockoptionsexercised": 47,
    "stockissuedduringperiodsharesstockoptionsexercised": 46667,
    "issuanceofcommonstockinregistereddirectoffering": 12500,
    "shareissuedproceedsfromissuanceinitialpublicoffering": 12500001,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6616705,
    "profitloss": -32542912,
    "issuanceofcommonstockinregistereddirectofferingnetofcosts": 1201818,
    "issuanceofstockandwarrantsforservicesorclaims": 102000,
    "operatingleaserightofuseassetamortizationexpense": 191648,
    "depreciation": 2668,
    "deferredincometaxexpensebenefit": 576000,
    "increasedecreaseinprepaidexpense": 5036926,
    "increasedecreaseinaccountspayable": 1761956,
    "increasedecreaseinaccruedliabilities": -929094,
    "increasedecreaseinaccruedinterestreceivablenet": -394732,
    "increasedecreaseinoperatingleaseliability": -196989,
    "netcashprovidedbyusedinoperatingactivities": -29060212,
    "proceedsfromstockoptionsexercised": 31267,
    "proceedsfromissuanceinitialpublicoffering": 13798183,
    "netcashprovidedbyusedinfinancingactivities": 13829450,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -15230762,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 26480928,
    "prepaidexpensespolicytextblock": "Prepaid Expenses",
    "patentsandtrademarkspolicytextblock": "Patentsand Trademarks",
    "scheduleofoptionactivityundertheplanstabletextblock": "Thefollowing assumptions were used in determining the fair value of stock option grants for the years ended September 30, 2023 and 2022:",
    "scheduleofcommonstockreservedforfutureissuancestabletextblock": "A summaryof common stock reserved for future issuances as of September 30, 2023 is as follows:",
    "scheduleleaseexpense": "Theelements of lease expense are as follows:",
    "lesseeoperatingleasesdisclosuretabletextblock": "Maturitiesof lease liabilities due under the Company’s non-cancellable leases are as follows:",
    "scheduleoperatingleasesassetsandliabilities": "Leases     Classification     September 30,    2023      September 30,    2022       Assets                          Lease asset     Operating     $454,426      $646,074       Total    lease assets           $454,426      $646,074                                    Liabilities                            Current     Operating     $218,380      $196,989       Non-current     Operating      262,865       481,245       Total    lease liabilities           $481,245      $678,234",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0352,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9400171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": "P7Y9M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 56203,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 4150000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 34067,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 66667,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 3.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y4M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6558507,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 56203,
    "exercisepricewarrants": 2.86,
    "numberofwarrantsissued": 218972,
    "warrantsexpirationdates": "October 2, 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 13305171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 11735000,
    "warrants": 50923819,
    "commonstockreserved": 75963990,
    "operatingleasecost": 238824,
    "variableleasecost": 4771,
    "leasecost": 243595,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 249024,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 253883,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 21460,
    "lesseeoperatingleaseliabilitypaymentsdue": 524367,
    "lessinterest": -43122,
    "operatingleaseliability": 481245,
    "operatingleaserightofuseassettotal": 454426,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.21,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.063,
    "permanentdifferencespercentage": 0.037,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.254,
    "effectiveincometaxratecontinuingoperations": 0.018,
    "deferredtaxassetsoperatinglosscarryforwards": 34980000,
    "employeebenefitsandsharebasedcompensation": 2191000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 3644000,
    "otheraccruedliabilitiescurrent": 4100000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 44915000,
    "deferredtaxassetsinprocessresearchanddevelopment": 6137800,
    "deferredincometaxliabilities": 6137800,
    "deferredtaxliabilities": 6137800,
    "goodwillgross": 9346796,
    "otherresearchanddevelopmentexpense": 19400000,
    "deferredrevenue": 40000000,
    "negativecashflowoperations": 29060212,
    "workingcapital": 28600000,
    "maintenancefees": 90000,
    "royaltyexpense": 100000,
    "proceedsfromroyaltiesreceived": 25000,
    "maximumaggregateannualroyalties": 150000,
    "paymentsforleasingcosts": 1100000,
    "debtinstrumentmaturitydate": "2034-01-02",
    "revenueremainingperformanceobligationpercentage": 0.5,
    "upfrontpayment": 40000000,
    "developmentmilestonepayments": 40000000,
    "commercialmilestonepayments": 300000000,
    "descriptionoflicenseagreement": "The royalties will end on the earlier of (i) the 15-year anniversary of the first commercial sale ofthe latest indication that received regulatory approval in the applicable country and (ii) the date on which a biosimilar product resultsin the reduction of net sales in the applicable product by 50% in two consecutive quarters, as compared to the four quarters prior tothe first commercial sale of the biosimilar product.",
    "prepaidinsurance": 154611,
    "paymentsforadvancetoaffiliate": 7734895,
    "amortizedstraightlinebasisoverperiod": "P8Y",
    "finitelivedintangibleassetsremainingamortizationperiod1": "P20Y",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4829,
    "sharesissuedpricepershare": 1.65,
    "fairvalueadjustmentofwarrants": 771000,
    "classofwarrantorrightoutstanding": 50923819,
    "commonstockissuedshares": 866667,
    "commonstockcapitalsharesreservedforfutureissuance": 110000,
    "warrantsoutstandingpurchaseofcommonstock": 1820000,
    "sharesissued": 1240000,
    "optiontopurchaseshareoutstanding": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm4": "P10Y",
    "shareissuedpricepershare": 0.98,
    "stockoptionsvestoverterms": "P10Y",
    "citiusstockplans": 4840874,
    "weightedaverageperiodterm": "P1Y6M10D",
    "commonsharesoutstanding": 1911500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 88500,
    "deferredrevenuerevenuerecognized1": 47575,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageperiodcontractualterm": "P0Y8M1D",
    "dividendscommonstockpaidinkind": 1151208,
    "operatingleaseexpense": 47176,
    "deferredfederalincometaxexpensebenefit": 576000,
    "deferredtaxassetsvaluationallowance": 4984000,
    "federalnetoperatinglosscarryforward": 133000000,
    "carryforwardsamount": 98000000,
    "federalresearchanddevelopment": 3511000,
    "entityregistrantname": "Citius Pharmaceuticals, Inc.",
    "tradingsymbol": "CTXR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--09-30",
    "amendmentflag": "false",
    "entitycentralindexkey": 1506251,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-09-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38174",
    "entityincorporationstatecountrycode": "NV",
    "entitytaxidentificationnumber": "27-3425913",
    "entityaddressaddressline1": "11 Commerce Drive",
    "entityaddressaddressline2": "First Floor",
    "entityaddresscityortown": "Cranford",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7016,
    "cityareacode": "(908)",
    "localphonenumber": "967-6677",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 392,
    "auditorname": "Wolf & Company, P.C.",
    "auditorlocation": "Boston, Massachusetts"
  },
  {
    "date": "2022-09-29",
    "symbol": "CTXR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 41711690,
    "prepaidexpensecurrent": 2852580,
    "assetscurrent": 44564270,
    "propertyplantandequipmentnet": 4100,
    "operatingleaserightofuseasset": 646074,
    "depositsassets": 38062,
    "inprocessresearchanddevelopment": 59400000,
    "goodwill": 9346796,
    "otherassets": 68784858,
    "assets": 113999302,
    "accountspayablecurrent": 1165378,
    "accruedliabilitiescurrent": 1405394,
    "employeerelatedliabilitiescurrent": 1762251,
    "operatingleaseliabilitycurrent": 196989,
    "liabilitiescurrent": 4530012,
    "deferredincometaxliabilitiesnet": 5561800,
    "operatingleaseliabilitynoncurrent": 481245,
    "liabilities": 10573057,
    "commonstockvalue": 146211,
    "additionalpaidincapital": 232368121,
    "retainedearningsaccumulateddeficit": -129688467,
    "stockholdersequity": 102825865,
    "minorityinterest": 600380,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 600380,
    "liabilitiesandstockholdersequity": 113999302,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 146211130,
    "commonstocksharesoutstanding": 146211130,
    "researchanddevelopmentexpense": 17655482,
    "generalandadministrativeexpense": 11754609,
    "sharebasedcompensation": 3905954,
    "operatingexpenses": 33316045,
    "operatingincomeloss": -33316045,
    "investmentincomeinterest": 251399,
    "otheroperatingincomeexpensenet": 251399,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -33064646,
    "incometaxexpensebenefit": 576000,
    "netincomeloss": -33640646,
    "netincomelossavailabletocommonstockholdersbasic": -33640646,
    "earningspersharebasic": -0.23,
    "weightedaveragenumberofsharesoutstandingbasic": 146082399,
    "earningspersharediluted": -0.23,
    "weightedaveragenumberofdilutedsharesoutstanding": 146082399,
    "sharesoutstanding": 855171,
    "stockissuedduringperiodvalueissuedforservices": 378204,
    "stockissuedduringperiodsharesissuedforservices": 231701,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3905954,
    "profitloss": -33640646,
    "issuanceofcommonstockforservices": 378204,
    "operatingleaserightofuseassetamortizationexpense": 176754,
    "depreciation": 2923,
    "deferredincometaxexpensebenefit": 576000,
    "increasedecreaseinprepaidexpense": 111176,
    "increasedecreaseinaccountspayable": -111717,
    "increasedecreaseinaccruedliabilities": 783434,
    "increasedecreaseinaccruedsalaries": -143749,
    "increasedecreaseinoperatingleaseliability": -177237,
    "netcashprovidedbyusedinoperatingactivities": -28361256,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -28361256,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 41711690,
    "liquidityandmanagementsplantextblock": "2. LIQUIDITY AND MANAGEMENT’S PLAN ",
    "patentandtechnologylicenseagreementtextblock": "3. PATENT AND TECHNOLOGY LICENSE AGREEMENTS ",
    "employmentagreementstextblock": "8. EMPLOYMENT AGREEMENTS ",
    "patentsandtrademarkspolicytextblock": "Patents and Trademarks ",
    "scheduleofoptionactivityundertheplanstabletextblock": "            2022     2021      Risk-free interest rate     1.05 – 2.94%     0.32 – 0.89%      Expected dividend yield     0.00%     0.00%      Expected term     6.50 – 10 years     6.50 – 10 years      Expected volatility     94 – 110%     111 – 112%   ",
    "scheduleofcommonstockreservedforfutureissuancestabletextblock": "      Stock plan options outstanding      9,400,171       Stock plan shares available for future grants      3,885,000       Warrants outstanding      38,325,489       Total      51,610,660   ",
    "scheduleleaseexpense": "      Lease cost      Year Ended September 30, 2022      Year Ended September 30, 2021       Operating lease cost     $238,822      $238,824       Variable lease cost      772       194       Total lease cost     $239,594      $239,018                            Other information                    Weighted-average remaining lease term - operating leases      3.1 Years       4.1 Years       Weighted-average discount rate - operating leases      8.0%      8.0%   ",
    "lesseeoperatingleasesdisclosuretabletextblock": "      Year Ending September 30,             2023     $244,165       2024      249,024       2025      253,883       2026      21,460       Total lease payments      768,532       Less: interest      (90,298)      Present value of lease liabilities     $678,234    ",
    "scheduleoperatingleasesassetsandliabilities": "      Leases     Classification     September 30, 2022      September 30, 2021       Assets                            Lease asset     Operating     $646,074      $822,828       Total lease assets           $646,074      $822,828                                    Liabilities                            Current     Operating     $196,989      $177,237       Non-current     Operating      481,245       678,234       Total lease liabilities           $678,234      $855,471    ",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0294,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9400171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 869509,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3645000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": 7.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4140116,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 595405,
    "exercisepricewarrants": 1.88,
    "numberofwarrantsissued": 38325489,
    "warrantsexpirationdates": "February 19, 2026",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 9400171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 3885000,
    "warrants": 38325489,
    "commonstockreserved": 51610660,
    "operatingleasecost": 238822,
    "variableleasecost": 772,
    "leasecost": 239594,
    "operatingleaseweightedaverageremainingleaseterm1": 3.1,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasefutureminimumpaymentsduecurrent": 244165,
    "operatingleasefutureminimumpaymentsdueintwoyears": 249024,
    "operatingleasefutureminimumpaymentsdueinthreeyears": 253883,
    "operatingleasefutureminimumpaymentsdueinfouryears": 21460,
    "operatingleasefutureminimumpaymentsdue": 768532,
    "lessinterest": 90298,
    "presentvalueofleaseliabilities": 678234,
    "operatingleaserightofuseassettotal": 646074,
    "operatingleaseliability": 678234,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.21,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.063,
    "permanentdifferencespercentage": 0.018000000000000002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.272,
    "effectiveincometaxratecontinuingoperations": 0.017,
    "deferredtaxassetsoperatinglosscarryforwards": 34673000,
    "employeebenefitsandsharebasedcompensation": 1569000,
    "otheraccruedliabilitiescurrent": 3689000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 39931000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 5561800,
    "deferredincometaxliabilities": 5561800,
    "deferredtaxliabilities": 5561800,
    "goodwillgross": 9346796,
    "otherresearchanddevelopmentexpense": 19400000,
    "deferredrevenue": 40000000,
    "negativecashflowoperations": 28361256,
    "workingcapital": 40,
    "revenuefromcontractwithcustomerincludingassessedtax": 90000,
    "royaltyexpense": 100000,
    "proceedsfromroyaltiesreceived": 25000,
    "maximumaggregateannualroyalties": 150000,
    "paymentsforleasingcosts": 1100000,
    "debtinstrumentmaturitydate": "January 2, 2034",
    "revenueremainingperformanceobligationpercentage": 0.5,
    "amortizedstraightlinebasisoverperiod": "twelve years",
    "finitelivedintangibleassetsremainingamortizationperiod1": "twentyyears",
    "notesassumed1": 12500,
    "debtinstrumentdescription": "Notes with an aggregate principal balance of $104,000 accrued interest at the prime rate plus 1.0% per annumand notes with an aggregate principal balance of $68,970 accrued interest at 12% per annum.",
    "commonstockissuedshares": 866667,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 70000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 6667,
    "warrantsoutstandingpurchaseofcommonstock": 1820000,
    "sharesissued": 1240000,
    "commonstockcapitalsharesreservedforfutureissuance": 38325489,
    "optiontopurchaseshareoutstanding": 4855000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm4": 10,
    "stockoptionsvestoverterms": 10,
    "shareissuedpricepershare": 1.67,
    "stockbasedcompensationexpensedescription": "Stock-based compensation expense for the yearsended September 30, 2022 and 2021 was $3,905,954 (including $133,332 for the NoveCite Stock Plan) and $1,454,979 (including $83,555 forthe NoveCite Stock Plan), respectively. ",
    "citiusstockplans": 5317681,
    "weightedaverageperiodterm": 1.92,
    "commonsharesoutstanding": 2000000,
    "financeleaseweightedaverageremainingleaseterm1": 2.89,
    "sharebasedcompensationarrangementsharebasedpaymentawardoptionsexercisableintrinsicvalue": 1832879,
    "operatingleaseexpense": 62068,
    "deferredfederalincometaxexpensebenefit": 576000,
    "deferredtaxassetsvaluationallowance": 10754000,
    "federalnetoperatinglosscarryforward": 35000000,
    "carryforwardsamount": 86000000,
    "federalresearchanddevelopment": 3208000,
    "entityregistrantname": "Citius Pharmaceuticals, Inc.",
    "tradingsymbol": "CTXR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "September 30",
    "amendmentflag": "false",
    "entitycentralindexkey": 1506251,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "September 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38174",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "27-3425913",
    "entityaddressaddressline1": "11 Commerce Drive",
    "entityaddressaddressline2": "First Floor",
    "entityaddresscityortown": "Cranford",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7016,
    "cityareacode": "(908)",
    "localphonenumber": "967-6677",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 392,
    "auditorname": "Wolf & Company, P.C.",
    "auditorlocation": "Boston, Massachusetts"
  },
  {
    "date": "2021-09-29",
    "symbol": "CTXR",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 70072946,
    "prepaidexpensecurrent": 2741404,
    "assetscurrent": 72814350,
    "propertyplantandequipmentnet": 7023,
    "operatingleaserightofuseasset": 822828,
    "depositsassets": 38062,
    "inprocessresearchanddevelopment": 59400000,
    "goodwill": 9346796,
    "otherassets": 68784858,
    "assets": 142429059,
    "accountspayablecurrent": 1277095,
    "accruedliabilitiescurrent": 621960,
    "employeerelatedliabilitiescurrent": 1906000,
    "operatingleaseliabilitycurrent": 177237,
    "liabilitiescurrent": 3982292,
    "deferredincometaxliabilitiesnet": 4985800,
    "operatingleaseliabilitynoncurrent": 678234,
    "liabilities": 9646326,
    "commonstockvalue": 145979,
    "additionalpaidincapital": 228084195,
    "retainedearningsaccumulateddeficit": -96047821,
    "stockholdersequity": 132182353,
    "minorityinterest": 600380,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": 600380,
    "liabilitiesandstockholdersequity": 142429059,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 145979429,
    "commonstocksharesoutstanding": 145979429,
    "researchanddevelopmentexpense": 12240503,
    "generalandadministrativeexpense": 9836412,
    "sharebasedcompensation": 1454979,
    "operatingexpenses": 23531894,
    "operatingincomeloss": -23531894,
    "investmentincomeinterest": 261825,
    "gainslossesonextinguishmentofdebt": 166557,
    "otherincome": 59917,
    "interestexpense": 10839,
    "nonoperatingincomeexpense": 477460,
    "netincomeloss": -23054434,
    "preferredstockdividendsincomestatementimpact": 1450876,
    "netincomelossavailabletocommonstockholdersbasic": -24505310,
    "earningspersharebasicanddiluted": -0.23,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 108599080,
    "sharesoutstanding": 855171,
    "issuanceofcommonstockuponexerciseofwarrants": 31130134,
    "issuanceofcommonstockuponexerciseofwarrantsshares": 23995907,
    "issuanceofcommonstockforservices": 68000,
    "issuanceofcommonstockforservicesinshares": 50000,
    "stockissuedduringperiodvaluestockoptionsexercised": 82634,
    "stockissuedduringperiodsharesstockoptionsexercised": 70000,
    "stockholdersequityother": 500,
    "proceedsfromissuanceofprivateplacements": 18450410,
    "shareissuedproceedsfromissuanceofprivateplacement": 15455960,
    "issuanceofcommonstockinregistereddirectoffering": 70979842,
    "shareissuedproceedsfromissuanceinitialpublicoffering": 50830566,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1454979,
    "profitloss": -23054434,
    "issuanceofcommonstockinregistereddirectofferingnetofcosts": 5520160,
    "issuanceofcommonstockinprivateplacementofferingnetofcosts": 1549602,
    "amortizationofoperatingleaserightofuseasset": 163376,
    "depreciation": 1492,
    "gainslossesonrestructuringofdebt": 166557,
    "increasedecreaseinprepaidexpense": 2619167,
    "increasedecreaseinotherdeposit": 19031,
    "increasedecreaseinaccountspayable": -579140,
    "increasedecreaseinaccruedliabilities": 457920,
    "increasedecreaseinaccruedsalaries": 251081,
    "increasedecreaseinaccruedinterestreceivablenet": 87996,
    "increasedecreaseinoperatingleaseliability": -158999,
    "netcashprovidedbyusedinoperatingactivities": -24250414,
    "paymentstoacquirepropertyplantandequipment": 6938,
    "paymentstoacquireinprocessresearchanddevelopment": 40000000,
    "netcashprovidedbyusedininvestingactivities": -40006938,
    "repaymentsofnotespayable": 172970,
    "proceedsfromnotespayable": 500,
    "proceedsfromwarrantexercises": 31130134,
    "proceedsfromissuanceofcommonstock": 82634,
    "proceedsfromissuanceofprivateplacement": 18450410,
    "proceedsfromissuanceinitialpublicoffering": 70979842,
    "netcashprovidedbyusedinfinancingactivities": 120470550,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 56213198,
    "liquidityandmanagementsplantextblock": "2. LIQUIDITY AND MANAGEMENT’S PLAN ",
    "patentandtechnologylicenseagreementtextblock": "3. PATENT AND TECHNOLOGY LICENSE AGREEMENTS ",
    "employmentandconsultingagreements": "8. EMPLOYMENT AND CONSULTING AGREEMENTS ",
    "fdarefunddisclosuretextblock": "9. FDA REFUND ",
    "patentsandtrademarkspolicytextblock": "Patents and Trademarks ",
    "recentlyadoptedaccountingstandardspolicytextblock": "Recently Adopted Accounting Standards ",
    "scheduleofcommonstockreservedforfutureissuancestabletextblock": "      Stock plan options outstanding      5,755,171       Stock plan shares available for future grants      7,530,000       Warrants outstanding      40,208,347       Total      53,493,518   ",
    "scheduleleaseexpense": "      Lease cost     Year Ended September 30, 2021      Year Ended September 30, 2020       Operating lease cost     $238,824      $228,828       Variable lease cost      194       —       Total lease cost     $239,018      $228,828    ",
    "lesseeoperatingleasesdisclosuretabletextblock": "      Year Ending September 30,             2022     $239,306       2023      244,165       2024      249,024       2025      253,883       Thereafter      21,460       Total lease payments      1,007,838       Less: interest      (152,367)      Present value of lease liabilities     $855,471    ",
    "scheduleoperatingleasesassetsandliabilities": "      Leases     Classification     September 30, 2021      September 30, 2020       Assets                          Lease asset     Operating     $822,828      $986,204       Total lease assets           $822,828      $986,204                                    Liabilities                            Current     Operating     $177,237      $158,999       Non-current     Operating      678,234       855,471       Total lease liabilities           $855,471      $1,014,470    ",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0089,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.12,
    "exercisepricewarrants": 1.88,
    "numberofwarrantsissued": 40208347,
    "warrantsexpirationdates": "February 19, 2026",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 5755171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 7530000,
    "warrants": 40208347,
    "commonstockreserved": 53493518,
    "operatingleasecost": 238824,
    "variableleasecost": 194,
    "leasecost": 239018,
    "operatingleaseweightedaverageremainingleaseterm1": 4.1,
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasefutureminimumpaymentsdueintwoyears": 239306,
    "operatingleasefutureminimumpaymentsdueinthreeyears": 244165,
    "operatingleasefutureminimumpaymentsdueinfouryears": 249024,
    "operatingleasesfutureminimumpaymentsdueinfiveyear": 253883,
    "operatingleasefutureminimumpaymentsduethereafter": 21460,
    "operatingleasefutureminimumpaymentsdue": 1007838,
    "lessinterest": -152367,
    "presentvalueofleaseliabilities": 855471,
    "operatingleaserightofuseassettotal": 822828,
    "operatingleaseliability": 855471,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.21,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.063,
    "permanentdifferencespercentage": 0.006999999999999999,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.266,
    "deferredtaxassetsoperatinglosscarryforwards": 25508000,
    "employeebenefitsandsharebasedcompensation": 1105000,
    "otheraccruedliabilitiescurrent": 2564000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 29177000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 4985800,
    "deferredincometaxliabilities": 4985800,
    "goodwillgross": 9346796,
    "otherresearchanddevelopmentexpense": 40000000,
    "deferredrevenue": 40000000,
    "negativecashflowoperations": -24250414,
    "workingcapital": 68800000,
    "revenuefromcontractwithcustomerincludingassessedtax": 90000,
    "royaltyexpense": 100000,
    "proceedsfromroyaltiesreceived": 25000,
    "maximumaggregateannualroyalties": 150000,
    "paymentsforleasingcosts": 1100000,
    "debtinstrumentmaturitydate": "January 2, 2034",
    "percentageofoutstandingequity": 0.75,
    "saleofstockpercentageofownershipaftertransaction": 0.25,
    "revenueremainingperformanceobligationpercentage": 0.5,
    "notesassumed1": 160470,
    "conversionofstockamountconverted1": 12500,
    "debtinstrumentdescription": "Notes with an aggregate principal balance of $104,000 accrued interest at the prime rate plus 1.0% per annumand notes with an aggregate principal balance of $68,970 accrued interest at 12% per annum.",
    "interestandotherincome": 59917,
    "interestexpenserelatedparty": 9606,
    "incometaxexpensebenefit": 1233,
    "commonstockissuedshares": 866667,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 70000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 6667,
    "warrantsoutstandingpurchaseofcommonstock": 1820000,
    "sharesissued": 1240000,
    "commonstockcapitalsharesreservedforfutureissuance": 40208347,
    "optiontopurchaseshareoutstanding": 1210000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm4": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 1.34,
    "stockoptionsvestoverterms": 10,
    "stockbasedcompensationexpensedescription": "Stock-based compensation expense for the yearsended September 30, 2021 and 2020 was $1,454,979 (including $83,555 for the NoveCite Stock Plan) and $803,261, respectively. ",
    "citiusstockplans": 3012685,
    "weightedaverageperiodterm": 2.34,
    "commonsharesoutstanding": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentgranted": 2000000,
    "weightedaverageexerciseprice": 0.24,
    "fairvalueadjustmentofwarrants": 1450876,
    "proceedsfromissuanceofwarrants": 31130134,
    "financeleaseweightedaverageremainingleaseterm1": 3.74,
    "sharebasedcompensationarrangementsharebasedpaymentawardoptionsexercisableintrinsicvalue": 19903185,
    "consultingexpense": 144000,
    "operatingleaseexpense": 75448,
    "deferredtaxassetsvaluationallowance": 12257000,
    "federalnetoperatinglosscarryforward": 88000000,
    "carryforwardsamount": 53000000,
    "federalresearchanddevelopment": 2044000,
    "entityregistrantname": "CitiusPharmaceuticals, Inc.",
    "tradingsymbol": "CTXR",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--09-30",
    "amendmentflag": "false",
    "entitycentralindexkey": 1506251,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "September 30, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38174",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "27-3425913",
    "entityaddressaddressline1": "11Commerce Drive",
    "entityaddressaddressline2": "First Floor",
    "entityaddresscityortown": "Cranford",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 7016,
    "cityareacode": "(908)",
    "localphonenumber": "967-6677",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes"
  },
  {
    "date": "2020-09-29",
    "symbol": "CTXR",
    "period": "FY",
    "entityregistrantname": "Citius Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1506251,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--09-30",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-38174",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "cashandcashequivalentsatcarryingvalue": 13859748,
    "prepaidexpensecurrent": 122237,
    "assetscurrent": 13981985,
    "propertyplantandequipmentnet": 1577,
    "operatingleaserightofuseasset": 986204,
    "depositsassets": 57093,
    "inprocessresearchanddevelopment": 19400000,
    "goodwill": 9346796,
    "otherassets": 28803889,
    "assets": 43773655,
    "accountspayablecurrent": 1856235,
    "accruedliabilitiescurrent": 164040,
    "employeerelatedliabilitiescurrent": 1654919,
    "interestpayablecurrent": 89970,
    "notespayablecurrent": 172970,
    "operatingleaseliabilitycurrent": 158999,
    "liabilitiescurrent": 4097133,
    "longtermnotespayable": 164583,
    "deferredincometaxliabilitiesnet": 4985800,
    "operatingleaseliabilitynoncurrent": 855471,
    "liabilities": 10102987,
    "commonstockvalue": 55577,
    "additionalpaidincapital": 104208958,
    "retainedearningsaccumulateddeficit": -70593867,
    "stockholdersequity": 33670668,
    "liabilitiesandstockholdersequity": 43773655,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 55576996,
    "commonstocksharesoutstanding": 55576996,
    "researchanddevelopmentexpense": 8812810,
    "generalandadministrativeexpense": 8094614,
    "sharebasedcompensation": 803261,
    "operatingexpenses": 17710685,
    "operatingincomeloss": -17710685,
    "investmentincomeinterest": 68066,
    "otherincome": 110207,
    "interestexpense": 741,
    "nonoperatingincomeexpense": 162600,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -17548085,
    "netincomeloss": -17548085,
    "earningspersharebasicanddiluted": -0.45,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 39165248,
    "sharesoutstanding": 55576996,
    "issuanceofcommonstockuponexerciseofwarrants": 7146745,
    "issuanceofcommonstockuponexerciseofwarrantsshares": 9804415,
    "stockholdersequityother": 6870041,
    "stockholdersequityothershares": 7058824,
    "issuanceofcommonstockinunderwrittenofferingnetofcosts": 8691041,
    "issuanceofcommonstockinunderwrittenofferingnetofcostsshares": 9159524,
    "stockissuedduringperiodvalueissuedforservices": 528146,
    "stockissuedduringperiodsharesissuedforservices": 623740,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 803261,
    "profitloss": -17548085,
    "proceedsfromdebtnetofissuancecosts": 622900,
    "underwritingdiscount": 917299,
    "issuanceofcommonstockforservices": 528770,
    "amortizationofoperatingleaserightofuseasset": 151520,
    "depreciation": 844,
    "increasedecreaseinprepaidexpense": 74126,
    "increasedecreaseinaccountspayable": -857307,
    "increasedecreaseinaccruedliabilities": -82185,
    "increasedecreaseinaccruedsalaries": 254231,
    "increasedecreaseinaccruedinterestreceivablenet": -15673,
    "increasedecreaseinoperatingleaseliability": -123254,
    "netcashprovidedbyusedinoperatingactivities": -16930658,
    "paymentstoacquirepropertyplantandequipment": 1831,
    "netcashprovidedbyusedininvestingactivities": -1831,
    "proceedsfromnotespayable": 164583,
    "proceedsfromwarrantexercises": 7156549,
    "proceedsfromunderwrittenofferings": 8700201,
    "proceedsfromdirectofferings": 6877100,
    "netcashprovidedbyusedinfinancingactivities": 22898433,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 5965944,
    "operatingleaserightofuseassetandliabilityrecordeduponadoption": 1137724,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.21,
    "revenuefromcontractwithcustomerincludingassessedtax": 90000,
    "aggregateannualroyalties": 100000,
    "proceedsfromroyaltiesreceived": 25000,
    "maximumaggregateannualroyalties": 150000,
    "paymentsforleasingcosts": 1100000,
    "aggregateofmilestonepayments": 2100000,
    "royaltyexpense": 100000,
    "debtinstrumentmaturitydate": "2034-01-02",
    "patentsandtrademarksdescripton": "Patent costs are amortized over the legal life of the patents, generally twenty years, starting at the patent issuance date.",
    "rightofuseassetandleaseliability": 1137724,
    "secureddemandnotes": 12500,
    "notespayablerelatedpartiesclassifiedcurrent": 172970,
    "interestexpenserelatedparty": 14932,
    "debtinstrumentdescription": "Notes with a principal balance of $104,000 accrue interest at the prime rate plus 1% and notes with a principal balance of $68,970 accrue interest at 12% per annum.",
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodriskfreeinterestrate": 0.0166,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpectedterm1": "P10Y0M0D",
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpectedvolatilityrate": 1.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2465000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1625799,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 6667,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1507141,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 0.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P8Y0M0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 440336,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 72566,
    "exercisepricewarrants": 1.31,
    "numberofwarrantsissued": 641166,
    "warrantsexpirationdates": "August 10, 2025",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 3390171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 645000,
    "warrants": 26831989,
    "commonstockreserved": 32687160,
    "sharesissuedpricepershare": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 0.0001,
    "warrantstopurchaseshares": 855171,
    "commonstockoutstandingwarrantsreserve": 26831989,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm4": "P10Y",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 4829,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1166073,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y10M25D",
    "optionsvestovertermsdescription": "All of these options vest over terms of 12 to 36 months and have a term of 10 years.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 6667,
    "classofwarrantorrightoutstanding": 976164,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 220000,
    "consultingexpense": 324000,
    "operatingleasecost": 228828,
    "leasecost": 228828,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y1M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasesfutureminimumpaymentsduecurrent": 234447,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 239306,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 244165,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 249024,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 253883,
    "operatingleasesfutureminimumpaymentsduethereafter": 21460,
    "operatingleasesfutureminimumpaymentsdue": 1242285,
    "lessinterest": -227815,
    "presentvalueofleaseliabilities": 1014470,
    "operatingleaserightofuseassettotal": 986204,
    "operatingleaseliability": 1014470,
    "operatingleaseexpense": 87303,
    "computedexpectedtaxbenefit": -0.21,
    "statetaxesnetoffederalbenefit": -0.063,
    "permanentdifferences": 0.007,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.266,
    "deferredtaxassetsoperatinglosscarryforwards": 14498000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 915000,
    "deferredtaxassetsother": 1507000,
    "deferredtaxassetsvaluationallowance": 16920000,
    "inprocessresearchanddevelopments": -4985800,
    "deferredincometaxliabilities": 4985800,
    "deferredtaxliabilities": 4985800,
    "operatinglosscarryforwardsvaluationallowance": 3591000,
    "operatinglosscarryforwards": 65000000,
    "taxcreditcarryforwarddescription": "The tax credit carryforwards will begin to expire in 2036.",
    "federalresearchanddevelopmentcredits": 1055000
  },
  {
    "date": "2019-09-29",
    "symbol": "CTXR",
    "period": "FY",
    "entityregistrantname": "Citius Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1506251,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--09-30",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-09-30",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entityextransitionperiod": "false",
    "entityfilenumber": "333-170781",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "NV",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "cashandcashequivalentsatcarryingvalue": 7893804,
    "prepaidexpensecurrent": 48111,
    "assetscurrent": 7941915,
    "propertyplantandequipmentnet": 590,
    "depositsassets": 57093,
    "inprocessresearchanddevelopment": 19400000,
    "goodwill": 1586796,
    "otherassets": 21043889,
    "assets": 28986394,
    "accountspayablecurrent": 2713542,
    "accruedliabilitiescurrent": 246225,
    "employeerelatedliabilitiescurrent": 1400688,
    "interestpayablecurrent": 74297,
    "notespayablecurrent": 172970,
    "liabilitiescurrent": 4607722,
    "commonstockvalue": 28930,
    "additionalpaidincapital": 80169724,
    "retainedearningsaccumulateddeficit": -55819982,
    "stockholdersequity": -55819982,
    "liabilitiesandstockholdersequity": 28986394,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 28930493,
    "commonstocksharesoutstanding": 28930493,
    "researchanddevelopmentexpense": 8596898,
    "generalandadministrativeexpense": 6285480,
    "sharebasedcompensation": 715983,
    "operatingexpenses": 15598361,
    "operatingincomeloss": -15598361,
    "investmentincomeinterest": 52660,
    "interestexpense": 16443,
    "nonoperatingincomeexpense": 36217,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 15562144,
    "netincomeloss": -15562144,
    "earningspersharebasicanddiluted": -0.77,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20161854,
    "sharesoutstanding": 28930493,
    "issuanceofcommonstockinregistereddirectofferingnetofcosts": 4830571,
    "issuanceofcommonstockinregistereddirectofferingnetofcostsshares": 3430421,
    "issuanceofcommonstocknetofissuancecostsandunderwritingdiscount": 6283574,
    "issuanceofcommonstocknetofissuancecostsandunderwritingsdiscountshares": 6760615,
    "stockissuedduringperiodsharesstockoptionsexercised": 165000,
    "issuanceofcommonstockuponexerciseofwarrants": 20895,
    "issuanceofcommonstockuponexerciseofwarrantsshares": 2321569,
    "stockissuedduringperiodvalueissuedforservices": 211378,
    "stockissuedduringperiodsharesissuedforservices": 219097,
    "profitloss": -15562144,
    "proceedsfromdebtnetofissuancecosts": 466000,
    "underwritingdiscount": 710342,
    "issuanceofcommonstockforservicesandreleaseagreements": 211597,
    "depreciation": 893,
    "increasedecreaseinotherreceivables": -818343,
    "increasedecreaseinprepaidexpense": -9621,
    "increasedecreaseindeposits": -54926,
    "increasedecreaseinaccountspayable": 1140098,
    "increasedecreaseinaccruedliabilities": 64568,
    "increasedecreaseinaccruedsalaries": 201773,
    "increasedecreaseinaccruedinterestreceivablenet": -16443,
    "netcashprovidedbyusedinoperatingactivities": -12437751,
    "proceedsfromwarrantexercises": 23216,
    "proceedsfromcommissionsreceived": 6290335,
    "netproceedsfromregistereddirectoffering": -4834001,
    "netcashprovidedbyusedinfinancingactivities": 11147552,
    "cashandcashequivalentsperiodincreasedecrease": -1290199,
    "revenuefromcontractwithcustomerincludingassessedtax": 90000,
    "aggregateannualroyalties": 100000,
    "proceedsfromroyaltiesreceived": 25000,
    "maximumaggregateannualroyalties": 150000,
    "paymentsforleasingcosts": 1100000,
    "nonrefundableupfrontpayment": 125000,
    "propertyplantandequipmentestimatedusefullives": "Property and equipment are depreciated over estimated useful lives of three to five years.",
    "operatingleaserightofuseasset": 1138000,
    "operatingleaseliability": 1138000,
    "secureddemandnotes": 12500,
    "notespayablerelatedpartiesclassifiedcurrent": 172970,
    "debtinstrumentperiodicpaymentprincipal": 2500000,
    "debtinstrumentinterestratestatedpercentage": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0253,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y0M0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1771039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 190000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1174019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 0.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P7Y9M0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 49465,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 49465,
    "exercisepricewarrants": 0.0001,
    "numberofwarrantsissued": 1060615,
    "warrantsexpirationdates": "September 27, 2024",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecrease": 1771039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 1085000,
    "warrants": 25492513,
    "incrementalcommonsharesattributabletoequityunitpurchaseagreements": 201334,
    "commonstockreserved": 28555685,
    "researchanddevelopmentinprocess": 741843,
    "saleofstocknumberofsharesissuedintransaction": 421400,
    "saleofstockpricepershare": 0.8951,
    "classofwarrantorrightoutstanding": 2234700,
    "classofwarrantorrightunissued": 2321569,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P10Y",
    "stockissuedduringperiodsharesother": 0.94,
    "numberofconsultants": 4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "These options vest over terms of 12 to 36 months and have a term of 10 years.",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 915000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y7M28D",
    "weightedaverageremaininglifeofoutstandingwarrants": "P3Y7M17D",
    "proceedsfromissuanceofwarrants": 25492513,
    "stockissuedduringperiodsharesacquisitions": 2234700,
    "sharesissuedpricepershare": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 220000,
    "consultingexpense": 344000,
    "operatingleasesrentexpenseminimumrentals": 2167,
    "leaseexpirationdate1": "2019-04-30",
    "operatingleasesrentexpensenet": 56063,
    "computedexpectedtaxbenefit": -0.21,
    "statetaxesnetoffederalbenefit": -0.063,
    "permanentdifferences": 0.001,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.272,
    "deferredtaxassetsoperatinglosscarryforwards": 10994000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1133000,
    "deferredtaxassetsother": 1202000,
    "deferredtaxassetsvaluationallowance": 13329000,
    "effectiveincometaxratecontinuingoperations": 0.35,
    "operatinglosscarryforwardsvaluationallowance": 3017000,
    "operatinglosscarryforwards": 49291000,
    "taxcreditcarryforwarddescription": "The tax credit carryforwards will begin to expire in 2036.",
    "federalresearchanddevelopmentcredits": 852000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.35
  }
]